Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
52-week range
$78.19 – $95.34
96% from low
Exchange
ARCX
ETF
Borrow rate
2.61%
Moderate
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| MDYVState Street SPDR S&P 400 Mid Cap Value ETF | $94.60 | +0.19% | $2.6B | — |
| ASHRXtrackers Harvest CSI 300 China A-Shares ETF | $36.25 | +1.06% | $2.6B | — |
| CWIState Street SPDR MSCI ACWI ex-US ETF | $40.38 | +0.67% | $2.8B | — |
| FELVFidelity Enhanced Large Cap Value ETF | $40.03 | +0.20% | $3.0B | — |
| FESMFidelity Enhanced Small Cap ETF |
No company description on file.
No one on the platform currently holds MDYV.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-06-30 | 8,700 | $691.0K |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-22 | $0.4213 | 2026-06-24 |
| 2026-03-23 | $0.3800 | 2026-03-25 |
| 2025-12-22 | $0.3935 | 2025-12-24 |
| 2025-09-22 | $0.3945 | 2025-09-24 |
| 2025-06-23 | $0.4199 | 2025-06-25 |
| 2025-03-24 | $0.2455 | 2025-03-26 |
| 2024-12-23 | $0.4783 | 2024-12-26 |
| 2024-09-23 | $0.3604 | 2024-09-25 |
| 2024-06-24 | $0.3902 | 2024-06-26 |
| 2024-03-18 | $0.2846 | 2024-03-21 |
No one on the platform has traded MDYV yet.
| $47.86 |
| +0.53% |
| $3.2B |
| — |
| FLJPFranklin FTSE Japan ETF | $39.74 | +0.28% | $3.0B | — |
| FNCLFidelity MSCI Financials Index ETF | $76.67 | +0.22% | $2.2B | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2023-12-18 | $0.3023 | 2023-12-21 |
| 2023-09-18 | $0.2927 | 2023-09-21 |
| Execution date | Ratio |
|---|---|
| 2018-06-13 | 2-for-1 |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
EMVISION MEDICAL DEVICES — MARCH 12, 12:00 PM EDT The B2i Digital team is pleased to announce that EMVision Medical Devices Ltd. (Pink: $EMVDF | ASX: $EMV) is participating in the Life Sciences Virtual Investor Forum, co-hosted by Virtual Investor Conferences and Zacks Small Cap Research, on Thursday, March 12, 2026, at 12:00 PM EDT. The Life Sciences Virtual Investor Forum is a B2i Digital Featured Conference. For more details, please visit: https://b2idigital.com/otc-life-sciences-virtual-investor-forum Virtual Investor Conferences brings together public companies and a global audience of retail and institutional investors for live executive presentations, Q&A sessions, and on-demand replays. The platform is open to public companies listed on NYSE, Nasdaq, TSX, CSE, ASX, and the OTC Markets. EMVision Medical Devices is an Australian clinical-stage medical technology company developing portable, non-ionising brain imaging solutions designed to transform the diagnosis and management of stroke and other acute neurological conditions. Built on more than a decade of research originating at the University of Queensland, EMVision’s proprietary electromagnetic imaging technology aims to deliver rapid, bedside brain scans without the infrastructure, cost, or radiation exposure associated with CT and MRI. The company’s lead product, the emu Brain Scanner, along with a compact first-responder variant, targets a significant global unmet need in time-critical neurodiagnostics, with applications across hospital and pre-hospital settings worldwide. Presenting on behalf of EMVision will be Adam Millhouse, Head of Strategy and Corporate Development. Mr. Millhouse brings 18 years of experience in investment banking and funds management across Australia, Asia, and Europe, and is responsible for group strategy, corporate finance, and development activities at EMVision. He holds Bachelor and Honours degrees in Commerce from the University of Queensland and a Master of Science in Global Finance from New York University and The Hong Kong University of Science and Technology. To register for this presentation, visit: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5273640/emvision-medical-devices-ltd-pink-emvdf-asx-emv?utm_source=b2i&utm_medium=marketing&utm_campaign=0326LifeSciencesVIC For more information about EMVision Medical Devices, visit: https://emvision.com.au/investors/ Content about any specific company was provided and approved by that company or is available in the public domain. B2i Digital, Inc. has not independently verified the accuracy of the information contained herein. The content contained herein is informational only, and no content contained herein shall be considered an offer to solicit the sale of any security or make a recommendation to purchase a security. B2i Digital is not a broker-dealer or investment adviser.
View on StockTwits ↗Mid-Cap Value pulled back 0.81% Tuesday Equity ETFs Daily Snapshot: Top 2 (by %): $VWO +0.69%, $EFA +0.23% Bottom 2: $MDYV -0.81%, $SDY -0.77% Intermediate-Term Read: $VWO Emg. Markets: Bullish Momentum - Neutral Sentiment. $EFA Dev. Markets: Bullish Momentum - Positive Sentiment. $SDY Dividend Stocks: Bullish Momentum - Positive Sentiment. $MDYV Mid-Cap Value: Bullish Momentum - Neutral Sentiment.
View on StockTwits ↗Nasdaq 100 jumped 1.52% Wednesday Equity ETFs Session Recap: Top 2 (by %): $QQQ +1.52%, $EFA +1.29% Bottom 2: $SDY -0.2%, $MDYV +0.04% Our Read (Intermediate-Term): $QQQ Nasdaq 100: Neutral Momentum - Neutral Sentiment. $EFA Dev. Markets: Bullish Momentum - Positive Sentiment. $MDYV Mid-Cap Value: Bullish Momentum - Neutral Sentiment. $SDY Dividend Stocks: Bullish Momentum - Positive Sentiment.
View on StockTwits ↗Emg. Markets retreated 1.25% Thursday Equity ETFs Price Action: Top 2 (by %): $MDYV +0.82%, $SLYV +0.6% Bottom 2: $VWO -1.25%, $SPYG -1.24% Our View (Intermediate-Term): $MDYV Mid-Cap Value: Bullish Momentum - Positive Sentiment. $SLYV Small-Cap Value: Bullish Momentum - Positive Sentiment. $SPYG S&P Growth: Neutral Momentum - Neutral Sentiment. $VWO Emg. Markets: Bullish Momentum - Positive Sentiment.
View on StockTwits ↗Nasdaq 100 climbed 1.45% Wednesday Equity ETFs Price Action: Top 2 (by %): $QQQ +1.45%, $SPYG +1.41% Bottom 2: $SDY -0.51%, $MDYV -0.1% Our View (Intermediate-Term): $QQQ Nasdaq 100: Neutral Momentum - Neutral Sentiment. $SPYG S&P Growth: Neutral Momentum - Neutral Sentiment. $MDYV Mid-Cap Value: Bullish Momentum - Positive Sentiment. $SDY Dividend Stocks: Bullish Momentum - Positive Sentiment.
View on StockTwits ↗Small-Cap Value tumbled 2.47% Monday Equity ETFs Price Action: Top 2 (by %): $SDY -0.16%, $EFA -0.41% Bottom 2: $SLYV -2.47%, $MDYV -2.09% Our View (Intermediate-Term): $SDY Dividend Stocks: Bullish Momentum - Positive Sentiment. $EFA Dev. Markets: Bullish Momentum - Positive Sentiment. $MDYV Mid-Cap Value: Bullish Momentum - Positive Sentiment. $SLYV Small-Cap Value: Bullish Momentum - Positive Sentiment.
View on StockTwits ↗The B2i Digital team is pleased to announce EMVision Medical Devices Ltd. (Pink: $EMVDF | ASX: $EMV) is participating in the Australia Investor Day Virtual Investor Conference (OTC Markets Group) on Thursday, February 26, 2026 at 12:05 PM EST. The Australia Investor Day is a B2i Digital Featured Conference. For more details, please visit: https://b2idigital.com/australia-investor-day-hybrid-conference To register and view the presentation, please visit: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5238196/australia-investor-day-morning-sessions?utm_source=b2i&utm_medium=marketing&utm_campaign=0226AustraliaDayVIC Presenting on behalf of the company will be Adam Millhouse, Head of Strategy and Corporate Development. EMVision Medical Devices is an Australian clinical-stage medical technology company developing portable, non-ionising brain imaging solutions designed to transform the diagnosis and management of stroke and other acute neurological conditions. Built on more than a decade of research originating at the University of Queensland, EMVision’s proprietary electromagnetic imaging technology aims to deliver rapid, bedside brain scans without the infrastructure, cost, or radiation exposure associated with CT and MRI. By enabling earlier stroke differentiation and treatment decisions — including in ambulances and emergency departments — the company is targeting a significant global unmet need in time-critical neurodiagnostics. EMVision’s lead product, the emu™ Brain Scanner, along with its compact first-responder variant, represents a potentially paradigm-shifting approach to acute stroke care with scalable applications across hospital and pre-hospital settings worldwide. The company is advancing clinical validation and regulatory pathways while positioning itself within a large and growing global stroke and neuroimaging market. With strong intellectual property, a differentiated technology platform, and a capital-efficient development strategy, EMVision offers investors exposure to an innovative medtech opportunity addressing one of healthcare’s most urgent diagnostic challenges. The Australia Investor Day is a hybrid event, combining an in-person conference at OTC Markets Headquarters, 300 Vesey Street, Lower Manhattan, New York, with a simultaneous virtual broadcast to a global audience of individual and institutional investors. Presentations are 20 minutes with 10 minutes of Q&A, broadcast live to the online investor community and archived for 90 days on the Virtual Investor Conferences platform. B2i Digital looks forward to supporting this conference connecting Australian companies with the global investor community. B2i Digital is the Official Marketing Partner of Virtual Investor Conferences. Content is for informational purposes only and is not investment advice. B2i Digital is not a broker-dealer or investment adviser.
Emg. Markets fell 0.62% Thursday Equity ETFs Daily Snapshot: Top 2 (by %): $MDYG +0.36%, $IWM +0.23% Bottom 2: $VWO -0.62%, $MDYV -0.44% Intermediate-Term Read: $MDYG Mid-Cap Growth: Bullish Momentum - Neutral Sentiment. $IWM Russell 2000: Bullish Momentum - Neutral Sentiment. $MDYV Mid-Cap Value: Bullish Momentum - Positive Sentiment. $VWO Emg. Markets: Bullish Momentum - Positive Sentiment.
View on StockTwits ↗Dev. Markets rallied 1.34% Monday Market Moves: Top 2 (by %): $EFA 1.34%, $SPYG 1.08% Bottom 2: $SLYV -0.35%, $MDYV -0.48% Our View (Intermediate-Term): $EFA: Bullish Momentum - Positive Sentiment. Momentum Sentiment $SPYG: Neutral Momentum - Neutral Sentiment. Momentum Sentiment $SLYV: Bullish Momentum - Positive Sentiment. Momentum Sentiment $MDYV: Bullish Momentum - Positive Sentiment. Momentum Sentiment
View on StockTwits ↗Mid-Cap Value surges while Large-Cap Growth tumbles – Wednesday What Happened: Top 2 (by %): $MDYV Mid-Cap Value +2.03%, $SLYV Small-Cap Value +2.02% Bottom 2: $QQQ Nasdaq 100 -1.75%, $SPYG S&P Growth -1.77% Our Take: Intermediate-Term momentum/sentiment readout for our Equity universe. $MDYV: Bullish Momentum - Neutral Sentiment $SLYV: Bullish Momentum - Positive Sentiment $QQQ: Bullish Momentum - Neutral Sentiment $SPYG: Bullish Momentum - Neutral Sentiment
View on StockTwits ↗@THE_Monkey_Banana_Genius Vanguard value ($VTV) as well, all the value funds were up. $IWD hit an all-time high, $MGV an all-time high, $MDYV, etc.
View on StockTwits ↗Moving 401k S&P 500 index funds to safe havens now. The problem with money market funds here is that Fed rate cuts will mean lower returns. So what do you do then if you can only transfer to other investment vehicles? Total bond market got smashed in 2022. Case in point, $BND fell 18.45% between the peak of the Nasdaq on 11/19/21 and the depths of the 2022 bear (mid-Oct 2022). I don’t see bonds as much of a safe haven. You could reason that value funds ($SPYV $IWD $AVMV $MDYV all green today) will be the equities safe haven, but even SPYV had an 18.8% peak to trough in 2022. So I’m not seeing a lot of good options here. Thoughts?
View on StockTwits ↗$MDYV Current Stock Price: $88.59 Contracts to trade: $85 MDYV Feb 20 2026 Call Entry: $3.60 Exit: $4.77 ROI: 33% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗S&P Growth climbs – Thursday What Happened: Top 2 (by %): $SPYG S&P Growth +0.79%, $VWO Emg. Markets +0.78% Bottom 2: $MDYV Mid-Cap Value -0.06%, $DVY High Dividend -0.17% Our Take: Intermediate-Term momentum/sentiment readout for our Equity universe. $SPYG: Bullish Momentum – Neutral Sentiment $VWO: Bullish Momentum – Positive Sentiment $MDYV: Bullish Momentum – Positive Sentiment $DVY: Bullish Momentum – Neutral Sentiment
View on StockTwits ↗Emerging Markets surge – Monday What Happened: Top 2 (by %): $VWO Emg. Markets +1.55%, $EFA Dev. Markets +0.61% Bottom 2: $MDYV Mid-Cap Value -0.28%, $SLYV Small-Cap Value -0.29% Our Take: Intermediate-Term momentum/sentiment readout for our Equity universe. $VWO: Bullish Momentum – Neutral Sentiment $EFA: Bullish Momentum – Positive Sentiment $MDYV: Bullish Momentum – Positive Sentiment $SLYV: Bullish Momentum – Positive Sentiment
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.